Towards Greater Awareness, Inclusion, and Effective Implementation

Are you interested in advancing more effective, equitable, and patient-centred healthcare?
Join our Implementation School on Personalised Medicine, focused on integrating sex and gender perspectives into clinical practice, research, and health systems. Despite growing evidence, sex- and gender-related differences remain under-represented in healthcare decision-making – yet they play a critical role in disease risk, diagnosis, treatment response, and patient experience.
This interactive programme brings together clinicians, researchers, public health professionals, and policymakers to explore how to translate gender-sensitive approaches into real-world practice. Through expert-led lectures, case-based discussions, and hands-on workshops, participants will gain practical tools to implement personalised medicine strategies that are inclusive and impactful.
Why apply?
- Learn from leading international experts in personalised and gender-sensitive medicine
- Gain practical skills to improve prevention, diagnosis, and treatment strategies
- Explore cutting-edge topics including pharmacogenomics, immuno-oncology, AI bias and more…
- Strengthen your ability to design and implement gender-responsive healthcare solutions
- Network with a multidisciplinary group of professionals across Europe
Format: Hybrid (onsite and online participation available)
Dates: 27 – 30 October 2026
Location: Vilnius University Medical Science Center, Zaliuju Ezeru st. 2, Vilnius, LT-08406.
Application: 4 May – 15 June 2026 (expired)



Participation is free of charge. Six grants will be offered to support travel and accommodation for selected onsite participants.
Selection will be based on applicants’ experience in personalised medicine and their motivation to further deepen their knowledge and actively contribute to the field.
Participants will also have the opportunity to present their own implementation ideas and receive feedback from experts and peers.
Be part of the next generation of personalised medicine – apply now and contribute to a more inclusive and effective healthcare system.
Agenda
Day 1, 27 October 2026
| Time | Topic |
|---|---|
| 10:00 ‑ 10:20 | Registration and Welcome Coffee |
| 10:20 ‑ 10:30 | Welcome by the Implementation School EP PerMed EP PerMed Implementation School team |
| 10:30 ‑ 11:00 | Welcome Prof Dalius Jatuzis Dean VU Faculty Medicine, Vilnius, LT PM and Translational research at VU Medical Science Center & Santaros clinics Assoc. Prof Karolis Azukaitis Vice-dean, VU Faculty Medicine, Vilnius |
| 11:00 ‑ 11:15 | EP PerMed Introduction & Training Event’s Objectives Dr Maria José Ruiz Alvarez National Institute of Health, Italy |
| 11:15 ‑ 12:30 | Getting to Know Each Other Participants Introductions |
| 12:30 ‑ 13:00 | From Biosamples to Real-World Evidence: Integrating Biobanking and National Health Data for Sex- and Gender-Sensitive Personalized Medicine in Lithuania Dr Giedre Kvedaraviciene The Biobank of Lithuanian Population and Rare Disorders, Vilnius, LT |
| 13:00 ‑ 14:00 | Lunch |
| 14:00 ‑ 14:30 | Sex- and Gender-differences in Cardiac Disorders Dr Hanna Pohjantähti Tampere Heart Hospital, Finland |
| 14:30 ‑ 15:00 | Time to Integrate Sex and Gender Differences into Research and Clinical Practice Prof Roberta Gualtierotti Internal Medicine Depart. Pathophysiology and Transplantation, Milan Univ, Italy |
| 15:00 ‑ 15:30 | Highlights in Sex and Gender Differences in Migraine Prof A. Maassen van den Brink Neurovascular Pharmacology & Internal Medicine, Netherlands |
| 15:30 ‑ 17:00 | Working Group |
| 17:00 ‑ 17:30 | Coffee Break |
| 17:30 ‑ 18:30 | Pitch Session I Presentations By Participants |
| 18:30 ‑ 19:30 | Closing the Day Dinner Reception |
Day 2, 28 October 2026
| Time | Topic |
|---|---|
| 08:45 ‑ 09:00 | Morning Welcome |
| 09:00 ‑ 10:30 | Sex and Gender in Personalised Diabetes Management Prof Dídac Mauricio Dept Endocrinology & Nutrition, CIBERDEM, Hospital Santa Creu i Sant Pau, Barcelona, Spain |
| 10:30 ‑ 11:00 | Coffee Break |
| 11:00 ‑ 11:30 | Grassroots to Policy: Implementing Sex & Gender-Conscious Care in a Major HMO Dr Lior Baruch Family Physician, Gender Medicine Maccabi Healthcare Serv, Reichman Univ, Israel |
| 11:30 ‑ 12:00 | The Need for Sex and Gender Considerations in Health Economic Evaluations Dr Martina Machenga Centre for Social Science Research (CSSR), University of Cape Town, South Africa |
| 12:00 ‑ 13:00 | Working Group |
| 13:00 ‑ 14:00 | Lunch |
| 14:00 ‑ 14:30 | Pitch Session II |
| 14:30 ‑ 15:00 | Sex-based Differences and Functional Genomics Prof Noam Shomron Tel-Aviv University, Israel |
| 15:00 ‑ 15:30 | Colorectal Cancer Prevention Program and Observed Sex-based Differences Prof Tomas Poskus VU Translational Health Research Institute, Vilnius, Lithuania |
| 15:30 ‑ 16:30 | Working Group |
| 16:30 ‑ 17:00 | Coffee Break |
| 17:00 ‑ 18:00 | Pitch Session III |
| 18:00 ‑ 18:30 | Gender differences in radiotherapy Prof Valerio Nardone Department of Precision Oncology, University of Campania “L. Vanvitelli”, Naples, Italy (ONLINE) |
| 18:30 | Closing the Day Dinner Reception |
Day 3, 29 October 2026
| Time | Topic |
|---|---|
| 08:45 ‑ 09:00 | Morning Welcome |
| 09:00 ‑ 09:30 | Sex and Gender Integration in Immunological Research Dr Helena Soares Nova Medical School, Faculdade de Ciencias Medicas, Nova University, Lisbon, Portugal |
| 09:30 ‑ 10:30 | Working Group |
| 10:30 ‑ 11:00 | Coffee Break |
| 11:00 ‑ 11:30 | Beyond biology: why gender equality strategy matters for Personalised Medicine Implementation Dr Kateryna Denysova Bureau for Policy & Programme Support (BPPS), Istanbul Regional Hub, United Nations Development Programme |
| 11:30 ‑ 12:30 | Working Group |
| 12:30 ‑ 13:00 | Pitch Session IV |
| 13:00 ‑ 14:00 | Lunch |
| 15:00 ‑ 15:30 | The Gender Health Gap in Pharmacotherapy and Safety Prof Julia C. Stingl Medical Clinic, Internal Medicine, Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, Germany |
| 15:30 ‑ 16:00 | The Integration of Sex and Gender Variables into Biobanking and Translational Cancer Biology Prof Neşe Atabey, Galen Research Center, Tinaztepe Univ, Buca, Izmir, Turkey |
| 16:00 ‑ 17:00 | Working Group |
| 17:00 ‑ 17:30 | Coffee Break |
| 17:30 ‑ 18:00 | Sex- and Gender-Specific Lifestyle, Psychosocial, and Sociocultural Targets for Alzheimer’s Disease Prevention in Africa: The FemBER-Africa Project Dr Jasmit Shahc Brain and Mind Institute Biostatistician Internal Medicine, Aga Khan University, Nairobi, Kenya |
| 17:45 ‑ 18:15 | Local Association Citizens |
| 18:15 ‑ 19:00 | Working Group |
| 19:00 | Working Dinner |
Day 4, 30 October 2026
| Time | Topic |
|---|---|
| 08:45 ‑ 09:00 | Morning Welcome |
| 09:00 – 09:30 | Sex, gender, & medicines safety: a regulatory perspective María Martínez González, Spanish Agency of Medicines and Medical Devices, and Complutense University of Madrid, Spain |
| 09:30 – 10:30 | Working Group |
| 10:30 – 11:30 | Sex-Disaggregated Data Along Gender-Based Health Pathways Dr Isabella Ceccherini UOSD Area Aggregazione Laboratori della Ricerca, IRCCS Istituto Giannina Gaslini Genova, Italy (ONLINE) |
| 11:30 – 12:00 | Coffee break |
| 12:00 – 12:30 | Sex, Gender, Infertility and its Treatment Prof Antonio La Marca University of Modena and Reggio Emilia, Italy (ONLINE) |
| 12:30 – 13:30 | Final Test Certification & Quality Evaluation Test |
| 13:30 – 14:30 | Closing Remarks & Farewell Lunch |